Cart
sales@molnova.com
Nitrocefin
CAS No. 41906-86-9
Nitrocefin( —— )
Catalog No. M24381 CAS No. 41906-86-9
Nitrocefin is an antibiotic. It being sensitive to hydrolysis by all lactamases produced by gram-positive and gram-negative bacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 134 | In Stock |
|
| 10MG | 229 | In Stock |
|
| 25MG | 434 | In Stock |
|
| 50MG | 546 | In Stock |
|
| 100MG | 783 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNitrocefin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNitrocefin is an antibiotic. It being sensitive to hydrolysis by all lactamases produced by gram-positive and gram-negative bacteria.
-
DescriptionNitrocefin is an antibiotic. It being sensitive to hydrolysis by all lactamases produced by gram-positive and gram-negative bacteria.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41906-86-9
-
Formula Weight516.5
-
Molecular FormulaC21H16N4O8S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILES[O-][N+](c1cc([N+]([O-])=O)c(/C=C/C(CS[C@@H]2[C@@H]3NC(Cc4cccs4)=O)=C(C(O)=O)N2C3=O)cc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boehle KE, et al. Utilizing Paper-Based Devices for Antimicrobial Resistant Bacteria Detection. Angew Chem Int Ed Engl. 2017 Jun 6;56(24):6886-6890.
molnova catalog
related products
-
N-Desmethyl Sildenaf...
N-Desmethyl Sildenafil is the major metabolite of Sildenafil, a potent phosphodiesterase type 5 (PDE5) inhibitor.
-
Sabeluzole
Sabeluzole (R-58735) has antiepileptic and cognitive enhancing effects, inhibits neurotoxin-induced tau expression and cell death.
-
Acetylhydroquinone
1. 2, 5-Dihydroxyacetophenone possess anti-anxiety, and neuroprotective qualities. 2. 2, 5-Dihydroxyacetophenone treatment can induce a sustained activation of JNK, ERK1/2, and p38 MAPKs.
